Identification of disease-related T cell clones and arthritogenic antigens in ankylosing spondylitis

强直性脊柱炎疾病相关 T 细胞克隆和致关节炎抗原的鉴定

基本信息

项目摘要

Ankylosing spondylitis (AS) is a highly prevalent chronic inflammatory disease, which affects both the axial skeleton and peripheral joints. Its pathogenesis is unclear, but it is remarkable that significantly more than 90 percent of all patients share a particular HLA allele, namely the HLA class I allele HLA-B*27:05 (in Caucasians). HLA molecules present antigenic peptides to T cells and initiate immune responses. The second strongest genetic marker is "ERAP1", an enzyme that trims antigenic peptides into the binding cleft of HLA molecules. Amongst other hypotheses for the pathogenesis of AS, it has therefore been assumed that "arthritogenic peptides" are presented by HLA-B27 molecules to T cells that would initiate and sustain the inflammatory process. However, so far none such peptides have been identified. Here we propose to identify arthritogenic peptides by a detour via disease-related T cells. To this end, we will first study the T cell receptor (TCR) repertoire and identify clonally expanded CD8+ T cells that are putatively disease-related. Then we will express their TCRs in vitro, and use the recombinant TCRs to identify antigenic peptide antigens presented by HLA-B*27 molecules to the T cells. In preliminary studies, we have identified oligoclonal T cell expansions of antigen experienced CD45RO+ CD8+ memory T cells isolated from synovial fluid of five AS patients with peripheral arthritis by next generation sequencing of TCR alpha- and beta-chains. In all patients the expansions were limited to only a few clones and several clones from different AS patients had highly homologous TCR chains. We are planning to complete these repertoire analyses in a larger cohort and to express about 20 recombinant TCRs which will be used for in vitro antigen searches. To this end, we will use a new technology recently developed in our labs that is based on plasmid-encoded combinatorial peptide libraries and an extremely sensitive detection system. We propose to identify peptide antigens presented by HLA-B*27 to CD8+ T cells and investigate whether candidate arthritogenic human peptides have homologues in commensal microbes or pathogens. To investigate molecular properties of the peptides and their generation in vivo, we will study the role of ERAP1 in processing of the parent proteins. To study whether or not the candidate disease-related peptides are detectable in larger cohorts of AS patients, we will generate HLA-B*27-peptide tetramers and determine frequencies of antigen-specific T cells in peripheral blood and other body fluids of patients and controls and are planning to identify disease-related T cell clones in spinal biopsy samples of AS patients using PCR and HLA-B*27-peptide tetramers. Identification of arthritogenic peptides may have impact in early diagnostics and may possibly also be of therapeutic use.
强直性脊柱炎(AS)是一种高度流行的慢性炎症性疾病,它同时影响中轴骨骼和外周关节。其发病机制尚不清楚,但值得注意的是,超过90%的患者共享特定的HLA等位基因,即HLA I类等位基因HLA-B*27:05(白人)。HLA分子将抗原肽呈递给T细胞并启动免疫应答。第二强的遗传标记是“ERAP 1”,一种将抗原肽修剪到HLA分子结合裂缝中的酶。在AS发病机制的其他假设中,因此已经假设“致关节炎肽”由HLA-B27分子呈递给T细胞,T细胞将启动并维持炎症过程。然而,到目前为止还没有鉴定出这样的肽。在这里,我们建议通过疾病相关的T细胞绕道来识别致关节炎肽。为此,我们将首先研究T细胞受体(TCR)库,并确定克隆扩增的CD 8 + T细胞,是puppatient疾病相关的。然后在体外表达它们的TCR,并利用重组TCR鉴定HLA-B*27分子呈递给T细胞的抗原肽抗原。在初步研究中,我们通过下一代TCR α和β链测序,鉴定了从5名患有外周关节炎的AS患者的滑液中分离的抗原经历的CD 45 RO + CD 8+记忆T细胞的寡克隆T细胞扩增。在所有患者中,扩增仅限于少数克隆,并且来自不同AS患者的几个克隆具有高度同源的TCR链。我们计划在更大的队列中完成这些库分析,并表达约20个重组TCR,这些重组TCR将用于体外抗原搜索。为此,我们将使用我们实验室最近开发的一种新技术,该技术基于质粒编码的组合肽库和一种极其灵敏的检测系统。我们建议鉴定由HLA-B*27呈递给CD 8 + T细胞的肽抗原,并调查候选的致关节炎人类肽在肠道微生物或病原体中是否具有同源物。为了研究肽的分子特性及其在体内的产生,我们将研究ERAP 1在亲本蛋白质加工中的作用。为了研究候选的疾病相关肽是否在更大的AS患者队列中可检测到,我们将产生HLA-B*27肽四聚体,并确定患者和对照组外周血和其他体液中抗原特异性T细胞的频率,并计划使用PCR和HLA-B*27肽四聚体鉴定AS患者脊髓活检样本中的疾病相关T细胞克隆。致关节炎肽的鉴定可能对早期诊断产生影响,并且也可能具有治疗用途。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Privatdozent Dr. Klaus Dornmair其他文献

Privatdozent Dr. Klaus Dornmair的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Privatdozent Dr. Klaus Dornmair', 18)}}的其他基金

Single-cell transcriptome profiling of disease-related lymphocytes in patients with multiple sclerosis
多发性硬化症患者疾病相关淋巴细胞的单细胞转录组分析
  • 批准号:
    433063520
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Repertoire and antigen recognition of brain-infiltrating immune cells in progressive MS
进行性多发性硬化症脑浸润免疫细胞的库和抗原识别
  • 批准号:
    340260765
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

黏液层/细菌被膜双重渗透型抗菌聚多肽纳米载体用于肺部给药治疗慢性阻塞性肺病
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82370865
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
牙周炎对腹主动脉瘤的作用和机制研究
  • 批准号:
    82370953
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
  • 批准号:
    82370719
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
DJ-1与Calnexin互作调控线粒体—内质网联络区参与帕金森病病理机制的研究
  • 批准号:
    82371414
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

Identification of blood biomarkers predictive of organ aging
鉴定预测器官衰老的血液生物标志物
  • 批准号:
    10777065
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors
基于机器学习的儿童癌症幸存者心肌病风险识别
  • 批准号:
    10730177
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
开发用于鉴定新世界猴生物标志物的免疫试剂
  • 批准号:
    10807651
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Identification of plasma lipoprotein proteins and lipids as biomarkers of innate-immunity and vascular contributions to Alzheimer's disease and Alzheimer's disease-related dementias in older adults
鉴定血浆脂蛋白和脂质作为老年人阿尔茨海默病和阿尔茨海默病相关痴呆的先天免疫和血管贡献的生物标志物
  • 批准号:
    10660037
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
腰椎管狭窄标本分析鉴定运甲状腺素蛋白心脏淀粉样变性
  • 批准号:
    10637491
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types
开发一种高效的高通量技术,用于鉴定跨多种组织类型的高影响力非编码体细胞变异
  • 批准号:
    10662860
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Identification and characterization of molecular subtypes of Alzheimer's disease associated with cognitive function through cross-omics data integration
通过跨组学数据整合识别和表征与认知功能相关的阿尔茨海默病分子亚型
  • 批准号:
    10722083
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The Pain Identification and Communication Toolkit: A Training Program to Support Family Caregivers of Persons with ADRD
疼痛识别和沟通工具包:支持 ADRD 患者家庭护理人员的培训计划
  • 批准号:
    10570403
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder
血清素诱导的快速眼动睡眠行为障碍中前驱神经变性的鉴定
  • 批准号:
    10734350
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Early Identification of Childhood Cancer Survivors at High Risk for Late Onset Cardiomyopathy: An Artificial Intelligence Approach utilizing Electrocardiography
早期识别迟发性心肌病高风险儿童癌症幸存者:利用心电图的人工智能方法
  • 批准号:
    10457160
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了